Infliximab Therapy for 2 Patients with Vogt-Koyanagi-Harada Syndrome

REFERENCES

• Rao N A, Sukavatcharin S, Tsai J H. Vogt-koyanagi-harada disease diagnostic criteria. Int Ophthalmol 2007; 27: 195–199
   PubMedGoogle Scholar
• Damico F M, Kiss S, Young L H. Vogt-Koyanagi-Harada disease. Semin Ophthalmol 2005; 20: 183–190
   PubMedGoogle Scholar
• Read R W, Holland G N, Rao N A, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol. 2001; 131: 647–652
   PubMed Web of Science ®Google Scholar
• Snyder D A, Tessler H H. Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol 1980; 90: 69–75
   PubMed Web of Science ®Google Scholar
• Damico F M, Cunha-Neto E, Goldberg A C, et al. T-cell recognition and cytokine profile induced by melanocyte epitopes in patients with HLA-DRB1*0405-positive and -negative Vogt-Koyanagi-Harada uveitis. Invest Ophthalmol Vis Sci 2005; 46: 2465–2471
   PubMed Web of Science ®Google Scholar
• Rao N A. Treatment of Vogt-Koyanagi-Harada disease by corticosteroids and immunosuppressive agents. Ocul Immunol Inflamm 2006; 14: 71–72
   PubMed Web of Science ®Google Scholar
• Nussenblatt R B. Vogt Koyanagi Harada syndrome. Uveitis: Fundamentals and Clinical Practice, ed 3., R B Nussenblatt, S M Whitcup. Mosby, Philadelphia 2004; 324
   Google Scholar
• Moorthy R S, Inomata H, Rao N A. Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol 1995; 39: 265–292
   PubMed Web of Science ®Google Scholar
• Paredes I, Ahmed M, Foster C S. Immunomodulatory therapy for Vogt-Koyanagi-Harada patients as first-line therapy. Ocul Immunol Inflamm 2006; 14: 87–90
   PubMed Web of Science ®Google Scholar
• Lim L, Suhler E B, Smith J R. Biologic therapies for inflammatory eye disease. Clin Exp Ophthalmol 2006; 34: 365–374
   PubMed Web of Science ®Google Scholar
• Scallon B, Cai A, Solowski N, et al. Binding and functional comparisons of two types of tumor necrosis factor antagonists. J Pharmacol Exp Ther. 2002; 301: 418–426
   PubMed Web of Science ®Google Scholar
• Gottlieb A B. Tumor necrosis factor blockade: mechanism of action. J Investig Dermatol Symp Proc. 2007; 12: 1–4
   PubMed Web of Science ®Google Scholar
• Gottlieb A B, Chamian F, Masud S, et al. TNF inhibition rapidly down-regulates multiple proinflammatory pathways in psoriasis plaques. J Immunol. 2005; 175: 2721–2729
   PubMed Web of Science ®Google Scholar
• Maini R N, Breedveld F C, Kalden J R, et al. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum 1998; 41: 1552–1563
   PubMed Web of Science ®Google Scholar
• Baughman R P, Bradley D A, Lower E E. Infliximab in chronic ocular inflammation. Int J Clin Pharmacol Ther 2005; 43: 7–11
   PubMed Web of Science ®Google Scholar
• Theodossiadis P G, Markomichelakis N N, Sfikakis P P. Tumor necrosis factor antagonists: preliminary evidence for an emerging approach in the treatment of ocular inflammation. Retina 2007; 27: 399–413
   PubMed Web of Science ®Google Scholar
• Suhler E B, Smith J R, Wertheim M S, et al. A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes. Arch Ophthalmol 2005; 123: 903–912
   PubMed Web of Science ®Google Scholar
• Read R W, Yu F, Accorinti M, et al. Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada disease. Am J Ophthalmol 2006; 142: 119–124
   PubMed Web of Science ®Google Scholar
• Coker R K. Guidelines for the use of corticosteroids in the treatment of pulmonary sarcoidosis. Drugs 2007; 67: 1139–1147
   PubMed Web of Science ®Google Scholar
• Da Silva J A, Jacobs J W, Kirwan J R, et al. Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data. Ann Rheum Dis 2006; 65: 285–293
   PubMed Web of Science ®Google Scholar
• Kohnen E M, Pansdorf Y, Zubcov A. Recurrent uveitis with bilateral exudative retinal detachment. 10-year-old boy with bilaterally impaired vision and eye pain: Vogt-Koyanagi-Harada syndrome. Ophthalmologe 2004; 101: 390–393
   Google Scholar
• Maruyama Y, Hayashi H, Takahashi K, et al. A case of insulin dependent diabetes mellitus following systemic treatment for Vogt-Koyanagi-Harada syndrome. Ophthalmic Surg Lasers 2000; 31: 487–490
   Google Scholar
• Zhang M, Liu Q, Min H, et al. Vogt-Koyanagi-Harada syndrome: glucocorticoid therapy and visual prognosis. Zhonghua Yan Ke Za Zhi 2002; 38: 200–203
   PubMedGoogle Scholar
• Thorne J E, Jabs D A, Qazi F A, et al. Mycophenolate mofetil therapy for inflammatory eye disease. Ophthalmology 2005; 112: 1472–1477
   PubMed Web of Science ®Google Scholar
• Bykhovskaya I, Thorne J E, Kempen J H, et al. Vogt-Koyanagi-Harada disease: clinical outcomes. Am J Ophthalmol. 2005; 140: 674–678
   PubMed Web of Science ®Google Scholar
• Hesselink D A, Baarsma G S, Kuijpers R W, et al. Experience with cyclosporine in endogenous uveitis posterior. Transplant Proc 2004; 36(2 Suppl)372S–377S
   Google Scholar
• Soheilian M, Aletaha M, Yazdani S, et al. Management of pediatric Vogt-Koyanagi-Harada (VKH)-associated panuveitis. Ocul Immunol Inflamm 2006; 14: 91–98
   PubMed Web of Science ®Google Scholar
• Furst D, Breedveld F, Kalden J, et al. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006. Ann Rheum Dis 2006; 65(suppl 3)iii2–15
   Google Scholar
• Wallis R S. Reactivation of latent tuberculosis by TNF blockade: the role of interferon gamma. J Investig Dermatol Symp Proc. 2007; 12: 16–21
   PubMed Web of Science ®Google Scholar
• Bayry J, Lacroix-Desmazes S, Kazatchkine M D, et al. Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale and mechanisms of action. Nat Clin Pract Rheumatol. 2007; 3: 262–272
   PubMedGoogle Scholar
• Sakaguchi M, Sugita S, Sagawa K, et al. Cytokine production by T cells infiltrating in the eye of uveitis patients. Jpn J Ophthalmol 1998; 42: 262–268
   PubMed Web of Science ®Google Scholar